## Abstract In this study we have analyzed the in vitro cell‐mediated cytotoxicity of immune peritoneal exudate cells (PEC), elicited in syngeneic mice against the MCA‐induced, TSTA‐bearing BALB/c fibrosarcomas CA‐2, GI‐17 and C‐3. The 4 h ^51^Cr‐release assay showed the immune PEC effectors to be
Genetic control of in vivo immunity to tumor-specific transplantation antigens of chemically induced murine fibrosarcomas
✍ Scribed by Giorgio Parmiani; Dario Ballinari
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- French
- Weight
- 804 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
The mean survival time of these animals was significantly longer than that of kd tumor-susceptihle mice..
📜 SIMILAR VOLUMES
The DNA of 22 fibrosarcomas, newly induced in 0ALWc mice by subcutaneous doses of 3-methylcholanthrene (3-MCA), was tested in NIH 3T3 transformation assay. Activation of K-ras and N-ras was found in 7 and 3 cases respectively. No H-ras activation was detected. Polymerase chain reaction and oligonuc
## Abstract We have previously shown that lymphocyte‐mediated immunity to common bladder tumor antigens can be demonstrated in vitro. In this study we used two carcinomas and two sarcomas of the urinary bladder of BALB/c mice to immunize syngeneic animals against tumor‐specific transplantation anti
## Abstract We have previously shown that the methyl‐cholanthrene‐induced BALB/c fibrosarcoma C‐1 syngeneically transplanted __in vivo__ expressed, in addition to its original H‐2^d^ and tumor‐associated transplantation antigens, also the foreign H‐2K^k^ 23, 1, 5, 11, 25 specificities. In the prese
## Abstract Sublethally irradiated BALB/c mice innoculated with Moloney sarcoma virus (MSV‐M) develop progressively growing tumors and die within 30 days of virus innoculation. These animals can be protected from tumor progression (and death) by innoculation of small numbers of MSV‐immune T lymphoc